230 related articles for article (PubMed ID: 32733468)
1. Monocyte-Derived Dendritic Cell Differentiation in Inflammatory Arthritis Is Regulated by the JAK/STAT Axis via NADPH Oxidase Regulation.
Marzaioli V; Canavan M; Floudas A; Wade SC; Low C; Veale DJ; Fearon U
Front Immunol; 2020; 11():1406. PubMed ID: 32733468
[TBL] [Abstract][Full Text] [Related]
2. CD209/CD14
Marzaioli V; Canavan M; Floudas A; Flynn K; Mullan R; Veale DJ; Fearon U
Front Immunol; 2021; 12():722349. PubMed ID: 35095831
[TBL] [Abstract][Full Text] [Related]
3. NOX5 and p22phox are 2 novel regulators of human monocytic differentiation into dendritic cells.
Marzaioli V; Hurtado-Nedelec M; Pintard C; Tlili A; Marie JC; Monteiro RC; Gougerot-Pocidalo MA; Dang PM; El-Benna J
Blood; 2017 Oct; 130(15):1734-1745. PubMed ID: 28830888
[TBL] [Abstract][Full Text] [Related]
4. Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement.
Orsolini G; Bertoldi I; Rossini M
Clin Rheumatol; 2020 Mar; 39(3):727-736. PubMed ID: 31970549
[TBL] [Abstract][Full Text] [Related]
5. Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors.
Gao W; McGarry T; Orr C; McCormick J; Veale DJ; Fearon U
Ann Rheum Dis; 2016 Jan; 75(1):311-5. PubMed ID: 26353790
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights.
Zhou Q; Vadakekolathu J; Watad A; Sharif K; Russell T; Rowe H; Khan A; Millner PA; Loughenbury P; Rao A; Dunsmuir R; Timothy J; Damiani G; Pigatto PDM; Malagoli P; Banfi G; El-Sherbiny YM; Bridgewood C; McGonagle D
Front Immunol; 2021; 12():635018. PubMed ID: 33936047
[TBL] [Abstract][Full Text] [Related]
7. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.
Jongbloed SL; Lebre MC; Fraser AR; Gracie JA; Sturrock RD; Tak PP; McInnes IB
Arthritis Res Ther; 2006; 8(1):R15. PubMed ID: 16507115
[TBL] [Abstract][Full Text] [Related]
8. Shaping of Monocyte-Derived Dendritic Cell Development and Function by Environmental Factors in Rheumatoid Arthritis.
Coutant F
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948462
[TBL] [Abstract][Full Text] [Related]
9. The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development.
Stalder R; Zhang B; Jean Wrobel L; Boehncke WH; Brembilla NC
Exp Dermatol; 2020 Jan; 29(1):71-78. PubMed ID: 31721311
[TBL] [Abstract][Full Text] [Related]
10. JAK/STAT Blockade Alters Synovial Bioenergetics, Mitochondrial Function, and Proinflammatory Mediators in Rheumatoid Arthritis.
McGarry T; Orr C; Wade S; Biniecka M; Wade S; Gallagher L; Low C; Veale DJ; Fearon U
Arthritis Rheumatol; 2018 Dec; 70(12):1959-1970. PubMed ID: 29790294
[TBL] [Abstract][Full Text] [Related]
11. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
[TBL] [Abstract][Full Text] [Related]
12. Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production.
Mitchell TS; Moots RJ; Wright HL
Clin Exp Immunol; 2017 Aug; 189(2):250-258. PubMed ID: 28369741
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells from patients with rheumatoid arthritis lack the interleukin 13 mediated increase of Fc gamma RII expression, which has clear functional consequences.
Radstake TR; Nabbe KC; Wenink MH; Roelofs MF; Oosterlaar A; van Lieshout AW; Barrera P; van Lent PL; van den Berg WB
Ann Rheum Dis; 2005 Dec; 64(12):1737-43. PubMed ID: 15878907
[TBL] [Abstract][Full Text] [Related]
14. The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells.
Kubo S; Yamaoka K; Kondo M; Yamagata K; Zhao J; Iwata S; Tanaka Y
Ann Rheum Dis; 2014 Dec; 73(12):2192-8. PubMed ID: 24013646
[TBL] [Abstract][Full Text] [Related]
15. Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.
Sucur A; Jajic Z; Artukovic M; Matijasevic MI; Anic B; Flegar D; Markotic A; Kelava T; Ivcevic S; Kovacic N; Katavic V; Grcevic D
Arthritis Res Ther; 2017 Jun; 19(1):142. PubMed ID: 28619088
[TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotides promote monocyte differentiation toward a DC-SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells.
Giordano D; Magaletti DM; Clark EA; Beavo JA
J Immunol; 2003 Dec; 171(12):6421-30. PubMed ID: 14662841
[TBL] [Abstract][Full Text] [Related]
17. Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways.
Ibrahim SSA; Salama MA; Selima E; Shehata RR
Life Sci; 2020 Nov; 260():118261. PubMed ID: 32795539
[TBL] [Abstract][Full Text] [Related]
18. Accessory cells with a veiled morphology and movement pattern generated from monocytes after avoidance of plastic adherence and of NADPH oxidase activation. A comparison with GM-CSF/IL-4-induced monocyte-derived dendritic cells.
Ruwhof C; Canning MO; Grotenhuis K; de Wit HJ; Florencia ZZ; de Haan-Meulman M; Drexhage HA
Immunobiology; 2002 Jul; 205(3):247-66. PubMed ID: 12182452
[TBL] [Abstract][Full Text] [Related]
19. Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells.
Canavan M; Marzaioli V; McGarry T; Bhargava V; Nagpal S; Veale DJ; Fearon U
Clin Exp Immunol; 2020 Nov; 202(2):226-238. PubMed ID: 32557565
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate Th1 inflammatory-type responses.
Santiago-Schwarz F; Anand P; Liu S; Carsons SE
J Immunol; 2001 Aug; 167(3):1758-68. PubMed ID: 11466401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
